Microbial Analysis
Product Sterility & Pathogen Diagnostics

Microbial
Analysis

Targeting latent contamination via NGS molecular RNA sequencing alongside aggressive MIC / MBC antimicrobial screening vectors resolving complex fungal and bacterial loads.

Contamination Clearance

Unchecked microbial infiltration decimates product integrity. Allele Life Sciences targets complex invasive biofilms, systemic product bacterial loads, and latent fungal mycotoxins forcing complete molecular transparency prior to public distribution.

Molecular ID

Pinpointing exact pathogen rRNA.

Viable Efficacy

Calculating MIC destructive power limits.

Pathological Scope

We deliver total pathogenic clarity combining rigorous molecular target identification (16S/ITS rRNA) against classical highly-structured kinetics modeling determining precise eradication constraints.

Antimicrobial Susceptibility tracking MIC / MBC destruction limits
NextGen Sequencing isolating 16S bacterial and ITS fungal profiles
Targeted chemical Synergy loops disrupting structural Biofilms
Critical clearance of Mycotoxins and Endotoxins from production

Defensive Methodologies

01

Antimicrobial Profiling

Rigorous testing executing definitive calculations for Minimum Inhibitory Concentration (MIC) and absolute Minimum Bactericidal Concentration (MBC).

MIC / MBC computation bounds
Antimicrobial susceptibility
Growth curve doubling tracking
02

Biofilm Penetration

Aggressive in-vitro analysis targeting complex bacterial biofilms, calculating exact resistance parameters against external commercial disinfectants.

Sessile bacterial tracing
Disinfectant efficacy arrays
Structural biofilm breakdown
03

Pathogen Identification

Executing precise next-generation RNA sequencing and primer walking resolving exact molecular identities of fungal, bacterial, and algal contaminants.

16S / ITS1 / 28S rRNA targeting
NGS molecular identification
Difficult DNA template parsing
04

Toxin & Endotoxin Arrays

Quantifying absolute limits of hazardous mycotoxins, trace endotoxins, and microbial allergenic traces embedded within product matrices.

Mycotoxin mass screening
Bacterial endotoxin checking
Microbial allergen profiling
05

Synergy Testing

Mapping massive combinatory interactions between novel chemical compounds to trace synergistic multiplier effects explicitly against invasive pathogens.

Antimicrobial synergy loops
Compound interaction matrices
Multi-strain resistance tests
06

Contaminant Auditing

Authoritative environmental and product audits clearing production runs from fungal (mold) spores and latent yeast colonization vectors.

Fungal mold clearing
Yeast colonization bounds
Regulatory sterility audits

The Eradication Pipeline

1

Sample Recovery

Isolating latent matrices

2

In-Vitro Action

Applying target compounds

3

Growth Kinetics

Calculating MBC/MIC bounds

4

RNA Sequencing

16S / ITS Identification

5

Clearance File

Issuing sterility data

Molecular Pathogen TargetingNextGen Sequence

"We refuse to rely purely on basic cultivation. By executing 16S and ITS RNA target sequencing alongside primer walking we mathematically pinpoint exact pathogens embedding within products—preventing cascading contamination long before public risk manifests."

Contaminant Hardware

Validated sequencing and inhibition hardware arrays.

NGS Platforms

NextGen rRNA Sequencing

Biofilm Reactors

Sessile colony growth

Kinetics Arrays

Minimum Doubling curves

Mass Spec Optics

Mycotoxin trace limits

Synergy Blocks

Antimicrobial interaction

Primer Walkers

Difficult template RNA

Analytical
Integrity

Extracting explicit minimum inhibitory and bactericidal destruction ceilings
Driving absolute molecular ID utilizing 16S / ITS rRNA NGS sequencing loops
Disrupting complex localized structural biofilm defenses against disinfectants
Tracing lethal mycotoxin and endotoxin components crossing hazard limits
Certifying absolute commercial sterility parameters preventing product decay
Kinetics Verified
Compound Synergy

"Antimicrobial action is rarely singular. We execute compound synergy tests mapping multidimensional chemical bounds determining explicit resistance cascades—validating commercial biocides definitively destroy targeted multidrug-resistant matrices."

Lethal Margin

Clearance Tiers

Scale of Method Execution

Toxin & Sterility

Basic Contamination

Complete Fungal (mold) and Yeast product cultivation limits
Endotoxin and explicit Mycotoxin product screening arrays
Broad-spectrum microbial allergen trace detection bounds
Preliminary commercial sterility clearance profiling
ID Standard

Pathogen Genomic

NGS Sequencing

Bacterial 16S / Fungal ITS1-28S / Algal 23S rRNA NGS sequencing
Primer walking for incredibly difficult GC-rich DNA templates
Target-region highly specific genomic microbial tracking
Total pathogen identification and molecular identity tagging

Antimicrobial Power

Biofilm & Kinetics

Definitive MIC / MBC Susceptibility calculations
Advanced structural Biofilm destruction mapping analyses
Strict Antimicrobial compound combinatorial Synergy tracking
Latent environmental / industrial strain kinetic doubling checks

Pathogens
Decoded

Download our technical handbook explicitly outlining NGS molecular RNA sequencing blocks alongside precise minimum inhibitory concentration thresholds.

Chat on WhatsApp